Free Trial

Mesa Laboratories (MLAB) Stock Price, News & Analysis

Mesa Laboratories logo
$75.62 +1.29 (+1.74%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$75.56 -0.06 (-0.08%)
As of 07/25/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Mesa Laboratories Stock (NASDAQ:MLAB)

Key Stats

Today's Range
$73.96
$75.63
50-Day Range
$67.97
$118.55
52-Week Range
$67.95
$155.12
Volume
61,848 shs
Average Volume
177,667 shs
Market Capitalization
$415.91 million
P/E Ratio
N/A
Dividend Yield
0.85%
Price Target
$130.00
Consensus Rating
Hold

Company Overview

Mesa Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

MLAB MarketRank™: 

Mesa Laboratories scored higher than 63% of companies evaluated by MarketBeat, and ranked 394th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Mesa Laboratories has only been the subject of 1 research reports in the past 90 days.

  • Read more about Mesa Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Mesa Laboratories are expected to grow by 9.00% in the coming year, from $8.00 to $8.72 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mesa Laboratories is -204.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mesa Laboratories is -204.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Mesa Laboratories has a P/B Ratio of 2.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Mesa Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    4.18% of the float of Mesa Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently increased by 18.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Mesa Laboratories has a dividend yield of 0.86%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Mesa Laboratories does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 7.34% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

  • Read more about Mesa Laboratories' dividend.
  • Percentage of Shares Shorted

    4.18% of the float of Mesa Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently increased by 18.33%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Mesa Laboratories has a news sentiment score of 1.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.07 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Mesa Laboratories this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $296,507.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of Mesa Laboratories is held by insiders.

  • Percentage Held by Institutions

    90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Mesa Laboratories' insider trading history.
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Stock News Headlines

Trump’s $100 Trillion Land Rush Is On
What Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trillions in oil, gas, lithium, and land rights. Whitney Tilson breaks it all down, and shows how everyday Americans can grab a stake. His urgent new briefing explains "The US: IPO"... and how to get in before the looming federal deadline.
Mesa Laboratories declares $0.16 dividend
MESA LABS DECLARES QUARTERLY DIVIDEND
See More Headlines

MLAB Stock Analysis - Frequently Asked Questions

Mesa Laboratories' stock was trading at $131.87 at the beginning of 2025. Since then, MLAB shares have decreased by 42.7% and is now trading at $75.62.

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its quarterly earnings results on Tuesday, February, 4th. The medical instruments supplier reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 0.82% and a positive trailing twelve-month return on equity of 27.51%.

Mesa Laboratories' top institutional shareholders include Kings Path Partners LLC (0.06%) and State of Alaska Department of Revenue (0.06%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, Evan Guillemin, John Sakys, Shannon Hall and Brian David Archbold.
View institutional ownership trends
.

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
2/04/2025
Record date for 6/16 Dividend
5/30/2025
Ex-Dividend for 6/16 Dividend
5/30/2025
Dividend Payable
6/16/2025
Today
7/26/2025
Next Earnings (Estimated)
8/05/2025
Record date for 9/15 Dividend
8/29/2025
Ex-Dividend for 9/15 Dividend
8/29/2025
Dividend Payable
9/15/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Electronic Equipment & Instruments
Current Symbol
NASDAQ:MLAB
CIK
724004
Employees
680
Year Founded
N/A

Price Target and Rating

High Price Target
$160.00
Low Price Target
$100.00
Potential Upside/Downside
+71.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
9.45
P/E Growth
N/A
Net Income
-$1.97 million
Net Margins
-0.82%
Pretax Margin
2.47%
Return on Equity
27.51%
Return on Assets
9.78%

Debt

Debt-to-Equity Ratio
0.48
Current Ratio
0.63
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$240.98 million
Price / Sales
1.73
Cash Flow
$12.48 per share
Price / Cash Flow
6.06
Book Value
$29.42 per share
Price / Book
2.57

Miscellaneous

Outstanding Shares
5,500,000
Free Float
5,260,000
Market Cap
$415.91 million
Optionable
Not Optionable
Beta
0.86

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:MLAB) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners